Download Docs
Export

ALDAMA PHARMACEUTICALS

99266049 | Trademark

Interested in this case?

To schedule a demo, contact us at sales@docketalarm.com. Track this case, and find millions of cases like it, let us show you how.
Filed July 3, 2025
Serial No. 99266049
Examining Attorney CHARLES FREDERICK MILLER
Class Dietary supplements; Pharmaceutical preparations for the treatment of a wide variety of diseases, conditions and disorders, namely, infectious diseases, cardiovascular diseases, respiratory diseases, gastrointestinal diseases, metabolic and endocrine disorders, neurological diseases and disorders, psychiatric and mental health disorders, namely, anxiety disorder, depression disorder, substance use disorder, post-traumatic stress disorder, and bipolar disorder, autoimmune and inflammatory diseases, musculoskeletal disorders, dermatological diseases, oncological diseases, hematological disorders, renal and urological diseases, hepatic diseases, ophthalmic diseases, otic diseases, allergic diseases, immunological disorders, pain and pain related conditions, namely, chronic low back pain, osteoarthritis, migraine and chronic headache disorders, fibromyalgia, and neuropathic pain, sleep disorders, reproductive and sexual health disorders, hormonal disorders, nutritional deficiencies, genetic disorders, namely, down syndrome, Klinefelter syndrome, cystic fibrosis, sickle cell disease and Marfan syndrome, and chronic and acute medical conditions, namely, hypertension, type 2 diabetes, asthma, acute myocardial infarction, and pneumonia; 005; 006; 018; 044; 046; 051; 052
ALDAMA PHARMACEUTICALS
Case Type Trademark Service mark
Status Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six months of the NOA issuance date.
Last Updated: 3 days, 9 hours ago
Filing Date # Docket Text